D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$986M |
| 2 |
Sea Limited
SE
|
+$480M |
| 3 |
Snowflake
SNOW
|
+$441M |
| 4 |
Citigroup
C
|
+$422M |
| 5 |
Oracle
ORCL
|
+$393M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$575M |
| 2 |
Apple
AAPL
|
+$515M |
| 3 |
Mastercard
MA
|
+$506M |
| 4 |
Walt Disney
DIS
|
+$447M |
| 5 |
Alibaba
BABA
|
+$434M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.34% |
| 2 | Consumer Discretionary | 9.18% |
| 3 | Financials | 7.38% |
| 4 | Healthcare | 6.92% |
| 5 | Communication Services | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OTRA
4226
DELISTED
OTR Acquisition Corp. Class A Common Stock
OTRA
| $525K | ﹤0.01% |
51,941
-11,946
| -19% | -$121K |
|
4227
BrightView Holdings
BV
$1.33B
| $524K | ﹤0.01% |
37,233
+26,257
| +239% | +$395K |
|
4228
Preferred Bank
PFBC
$1.23B
| $524K | ﹤0.01% |
+7,296
| New | +$504K |
|
4229
Foster
FSTR
$443M
| $520K | ﹤0.01% |
37,769
-3,531
| -9% | -$54.5K |
|
|
DHC
4230
Diversified Healthcare Trust
DHC
$2.28B
| $519K | ﹤0.01% |
168,105
-91,874
| -35% | -$297K |
|
4231
Lands' End
LE
$375M
| $519K | ﹤0.01% |
+26,435
| New | +$614K |
|
4232
Ormat Technologies
ORA
$6.28B
| $518K | ﹤0.01% |
6,529
-51,093
| -89% | -$3.86M |
|
4233
Smith Micro Software
SMSI
$14.1M
| $518K | ﹤0.01% |
2,631
+2,196
| +505% | +$480K |
|
4234
HEICO Corp
HEI
$49.9B
| $514K | ﹤0.01% |
3,565
-2,326
| -39% | -$328K |
|
|
HES
4235
PUT
DELISTED
Hess
HES
| $511K | ﹤0.01% |
6,900
+2,800
| +68% | +$227K |
|
4236
OrthoPediatrics
KIDS
$509M
| $510K | ﹤0.01% |
8,521
+4,932
| +137% | +$307K |
|
4237
Mustang Bio
MBIO
$4.24M
| $509K | ﹤0.01% |
409
+256
| +167% | +$413K |
|
4238
CALL
PTC
PTC
$14.5B
| $509K | ﹤0.01% |
4,200
-3,100
| -42% | -$374K |
|
4239
CALL
Vicor
VICR
$9.41B
| $508K | ﹤0.01% |
+4,000
| New | +$566K |
|
4240
AXT Inc
AXTI
$3.13B
| $507K | ﹤0.01% |
+57,583
| New | +$487K |
|
|
LKFT
4241
CALL
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
| $507K | ﹤0.01% |
9,200
| – | – |
|
4242
CALL
Sylvamo
SLVM
$1.5B
| $506K | ﹤0.01% |
+18,153
| New | +$529K |
|
|
APPH
4243
CALL
DELISTED
AppHarvest, Inc. Common Stock
APPH
| $506K | ﹤0.01% |
130,000
| – | – |
|
4244
CALL
Cardinal Health
CAH
$53.7B
| $505K | ﹤0.01% |
+9,800
| New | +$481K |
|
4245
Corbus Pharmaceuticals
CRBP
$168M
| $505K | ﹤0.01% |
27,317
+4,693
| +21% | +$127K |
|
4246
Portland General Electric
POR
$5.93B
| $505K | ﹤0.01% |
+9,544
| New | +$476K |
|
|
ODT
4247
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $505K | ﹤0.01% |
374,195
+140,855
| +60% | +$333K |
|
|
PVLA
4248
Palvella Therapeutics
PVLA
$2.03B
| $504K | ﹤0.01% |
+1,667
| New | +$534K |
|
|
GACQW
4249
DELISTED
Global Consumer Acquisition Corp. Warrant
GACQW
| $504K | ﹤0.01% |
840,000
+560,000
| +200% | +$294K |
|
4250
PUT
Vermilion Energy
VET
$1.62B
| $503K | ﹤0.01% |
+40,000
| New | +$436K |
|
Similar funds
D.E. Shaw & Co's Q4 2021 Portfolio in Review
As of Q4 2021, D.E. Shaw & Co held 5,958 positions worth $121B, up 8.8% from $111B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co's Q4 2021 filing shows 1,033 new, 1,969 increased, 1,595 reduced and 616 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 2,140,000 shares worth $1.02B. The largest sale was Microsoft, an estimated $575M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
- D.E. Shaw & Co's largest Q4 2021 buy was iShares Core S&P 500 ETF: 2,140,000 shares worth $1.02B.
- D.E. Shaw & Co added most to Sea Limited in Q4 2021, an estimated $480M increase.
- D.E. Shaw & Co's biggest Q4 2021 reduction was Microsoft, cutting an estimated $575M.
- D.E. Shaw & Co fully exited Aon in Q4 2021, selling an estimated $179M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $121B portfolio in Q4 2021.
- D.E. Shaw & Co opened 1,033 new positions and closed 616 in Q4 2021.
- D.E. Shaw & Co's portfolio value rose 8.8% quarter-over-quarter to $121B.
Based on D.E. Shaw & Co's 13F filing for Q4 2021, filed 14 Feb 2022.